CAS: 1126721-82-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Sunitinib-d10 REF: 4Z-S-413CAS: 1126721-82-1 | - - - | To inquire | Tue 07 Jan 25 |
 | Sunitinib-d10 REF: TM-T13039CAS: 1126721-82-1 | 98% | 179.00 €~701.00 € | Tue 07 Jan 25 |
 | Sunitinib-d10 REF: TR-S820002CAS: 1126721-82-1 | - - - | 206.00 €~1,548.00 € | Tue 14 Jan 25 |
 | Sunitinib-d10 REF: 3D-BVB72182CAS: 1126721-82-1 | Min. 95% | To inquire | Tue 18 Feb 25 |
Sunitinib-d10
CAS:1126721-82-1
Formula:
C22H17D10FN4O2
Color and Shape:
Brown Yellow Solid
Molecular weight:
408.54
Ref: 4Z-S-413
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Sunitinib-d10
CAS:1126721-82-1
Sunitinib D10, a deuterium-enriched version, inhibits VEGFR2 and PDGFRβ tyrosine kinases (IC50: 80 nM/2 nM).
Formula:
C22H27FN4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
408.54
Ref: TM-T13039
| 1mg | 179.00 € | ||
| 5mg | 537.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Sunitinib-d10
Controlled ProductCAS:1126721-82-1
Formula:
C22H17D10FN4O2
Color and Shape:
Yellow
Molecular weight:
408.54
Ref: TR-S820002
| 1mg | 206.00 € | ||
| 5mg | 908.00 € | ||
| 10mg | 1,548.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Sunitinib-d10
CAS:1126721-82-1
Sunitinib-d10 is a drug that is used to treat renal cell cancer, chronic myeloid leukaemia, …
Formula:
C22H17D10FN4O2
Purity:
Min. 95%
Molecular weight:
408.54 g/mol
Ref: 3D-BVB72182
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
